Del-1 gene therapy (Valentis)

N/A

Report date: 2026/01/22 17:22:35

Base Information

Drug NameDel-1 gene therapy (Valentis)
Drug Alias NameVLTS 589DELTAVASC
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionAngiogenesis inducers
TargetsVascular endothelial growth factor receptor 1
Therapy Area/IndicationsPeripheral Vascular DiseasesIntermittent ClaudicationPeripheral Arterial Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesValentis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValentis
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular DiseasesIntermittent ClaudicationPeripheral Arterial Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A